http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-1995000020-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 1995-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca233d8eb8ba36b338edc5faa0f88331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90d1195ad94815e8fcf202e1178f9d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2638cd63699df9730f892c4bc3a5067e |
| publicationDate | 1995-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SV-1995000020-A |
| titleOfInvention | DERIVATIVES OF HYDROXAMIC ACID WITH TRICYCLIC SUBSTITUTION. REF. RAN 4070/95 |
| abstract | THE INVENTION PROVIDES HYDROXAMIC ACID DERIVATIVES FROM THE GENERAL FORMULA, WHERE R1 REPRESENTS CYCLOPROPYL, CYCLOPHENTIL OR CYCLLOHEXYL; R2 REPRESENTS A 5 TO 8 MEMBER SATURATED MONO-CYCLE OR BRIDGED N-HETERO CYCLIC RING THAT IS UNITED VIA THE NY ATOM WHICH, WHEN IT IS MONOCYCLIC, CONTAINS OPTIONALLY NR4, OR, SO OR S02 AS A RING MEMBER AND / OR IS OPTIONALLY SUBSTITUTED IN ONE OR MORE ATOMS OF C HYDROXYL, LOWER ALKYL, ALCOXYL, OX, OXOCETALLIZED, AMINO, MONO (LOWER ALKYL) AMINO, DI (LOWER ALKYL) AMINO, CARBOXYL, ALCOXICARBONYL, HIDERO, HIDERO ) -CARBAMOIL, DI (LOWER ALKYL), CARBAMOIL OR HYDROXYIMINE; R3 REPRESENTS A PENTAGONAL OR HEXAGONAL N-HETERO CYCLIC RING THAT (A) IS UNITED VIA THE ATOM OF N, (B) OPTIONALLY CONTAINS N, OY / OS, S0 OR S02 AS AN ADDITIONAL RING MEMBER, (C) IS REPLACED BY OXO IN ONE OR BOTH ATOMS OF C ADJACENT TO THE ATOMO DE N DE ENLACE AND (D) IT IS OPTIONALLY BENZOFUSED OR OPTIONALLY SUBSTITUTED IN ONE OR MORE ATOMOS OF OTHER ATOMOS DE C BY ANY INFERIOR OR OXO AND / OR IN ANY ATOMO (S) ADDITIONAL (S) FOR LOWER RENT OR ARIL; R4 REPRESENTS HYDROGEN, LOWER RENT, ARYL, ARACHYL OR A PROTECTIVE GROUP; M MEANS 1 or 2; Y N MEANS 1-4; AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, WHICH ARE INHIBITORS OF COLAGENASA USEFUL IN THE CONTROL OR PREVENTION OF DISEASES OF THE DEGENERATIVE JOINTS SUCH AS ARTHRITIS RHEUMARIUM AND OSTEOARI-ESTERI-ESSTERS, ATEROSCLARS, AND ATEROSCLAR. OR DEPROTECTING A CORRESPONDING NEW BUCYLOXICARBOMOIL COMPOUND. |
| priorityDate | 1994-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.